Abstract :

Cervical cancer develops in the cervix, primarily caused by persistent infection with high-risk types of human papilloma virus (HPV). It is one of the most common cancers in women, especially in low- and middle-income countries. While most HPV infections resolve naturally, some persist and can lead to cervical cancer over time.

Aim: This study aims to evaluate the knowledge, attitudes, and practices (KAP) of young women in Chennai regarding cervical cancer, screening, and prevention, and to identify barriers and facilitators influencing participation in screening programs.

Methodology: A cross-sectional study was conducted from January to May 2024 among 222 young females, aged 13 and above.. A semi-structured questionnaire assessed their KAP towards cervical cancer. Responses were analyzed using descriptive statistics, and Bloom’s taxonomy was applied to categorize knowledge and attitude. Chi-square tests were used to determine statistical significance, with a p-value < 0.05.

Results: Although 78.2% of participants were aware of cervical cancer, knowledge of preventive measures was low—only 25.2% knew about the HPV vaccine, and 44% understood the correct Pap test frequency. Attitudes toward screening were mostly positive, with 73.2% agreeing that free screening reduces cervical cancer risk. However, actual preventive practices were limited—only 9% had undergone a Pap smear, and 10% had received the HPV vaccine. Statistical analysis showed no significant differences in KAP between groups (p > 0.05), except for medical students, who demonstrated significantly higher knowledge levels.

Conclusion: Despite positive attitudes toward cervical cancer screening, there were notable gaps in knowledge and preventive practices among young women in Chennai. The findings underscore the need for targeted educational interventions, particularly on HPV vaccination and routine screening, to bridge these gaps.

---

Keywords :

Attitudes, Cervical cancer, Chennai., HPV vaccination, Knowledge, practices, Screening.

---

References :

1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249.
2. Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890-907.
3. IARC. HPV and cervical cancer. In: IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Volume 100B. Lyon: International Agency for Research on Cancer; 2012.
4. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics 2002. CA Cancer J Clin. 2005;55(2):74-108.
5. Munoz N, Castillo M, de Sanjose S, et al. Epidemiology of cervical cancer. Vaccine. 2006;24(S3)/1-S3/10.
6. Saslow D, Andrews KS, Adam E, et al. Human papillomavirus vaccination and screening for cervical cancer prevention: a consensus guideline from the American Cancer Society. CA Cancer J Clin. 2016;66(3):203-221.
7. Wright TC Jr, Dunton CJ, Spitzer M, et al. 2006 Consensus guidelines for the management of women with abnormal cervical cancer screening tests. J Am Board Fam Med. 2007;20(3):335-352.
8. Markowitz LE, Dunne EF, Saraiya M, et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-2):1-24.
9. Bruni L, Diaz M, Castellsagué X, et al. Cervical cancer worldwide: human papillomavirus and beyond. Reprod Health Matters. 2010;18(36):1-15.
10. Cuzick J, Myers O, et al. Current guidelines for cervical cancer screening. Best Pract Res ClinObstetGynaecol. 2007;21(3):491-506.
11. Papanicolaou G, Traut L. The diagnostic value of vaginal smears in cancer diagnosis. Am J Obstet Gynecol. 1941;42(2):193-206.
12. Kitchener HC, Frazer IH, Haggerty T, et al. The role of screening in cervical cancer prevention. Lancet. 2006;367(9520):1262-1270.
13. Kahn JA, Bernstein DI, et al. The impact of the HPV vaccine on cervical cancer prevention. Clin Infect Dis. 2011;53(6):507-516.
14. Denny L, Quinn M, Sankaranarayanan R. Screening for cervical cancer in developing countries. Vaccine. 2006;24(S3)/71-S3/77.
15. WHO. Comprehensive cervical cancer control: a guide to essential practice. Geneva: World Health Organization; 2014.
16. Touch S, Oh JK. Knowledge, attitudes, and practices toward cervical cancer prevention among women in Kampong Speu Province, Cambodia. BMC cancer. 2018 Dec;18:1-8.

17. Merkuri L, Kamberi F, Qorri E, Shapo L. Assessment of the Albanian University female students’ knowledge, attitudes, and practices on cervical cancer. The Journal of Infection in Developing Countries. 2023 Apr 30;17(04):534-41.
18. Ali AN, KarMun L, Prajapati SK, Zahid Iqbal M, Zulfikar Ahmed N. Cervical cancer, its screening and vaccination: A KAP study among female healthcare students in a Private University, Malaysia. MOJ Bioequivalence Bioavailab. 2018;5(5):275-82.
19. Akinnibosun O, Abakpa OG, Ujoh AJ, Oche DA, Zakari S, Yandev D, Adikwu P, David OO, Agboola O, Paul S, Audu O. Knowledge, Attitudes and Practices among Women of Reproductive Age on Human Papillomavirus Infection, Cervical Cancer and Vaccination in Otukpo, Nigeria. Ethiopian Journal of Health Sciences. 2024 Mar 9;34(1).